Emerging and future strategies in the management of recalcitrant Candida auris

Abstract Candida auris is an emerging, multi drug resistant fungal pathogen that has caused infectious outbreaks in over 45 countries since its first isolation over a decade ago, leading to in-hospital crude mortality rates as high as 72%. The fungus is also acclimated to disinfection procedures and persists for weeks in nosocomial ecosystems. Alarmingly, the outbreaks of C. auris infections in Coronavirus Disease-2019 (COVID-19) patients have also been reported. The pathogenicity, drug resistance and global spread of C. auris have led to an urgent exploration of novel, candidate antifungal agents for C. auris therapeutics. This narrative review codifies the emerging data on the following new/emerging antifungal compounds and strategies: antimicrobial peptides, combinational therapy, immunotherapy, metals and nano particles, natural compounds, and repurposed drugs. Encouragingly, a vast majority of these exhibit excellent anti- C. auris properties, with promising drugs now in the pipeline in various stages of development. Nevertheless, further research on the modes of action, toxicity, and the dosage of the new formulations are warranted. Studies are needed with representation from all five C. auris clades, so as to produce data of grater relevance, and broader significance and validity. Lay Summary Elimination of Candida auris that causes deadly infections to susceptible individuals is extremely challenging due to the lack of effective treatment options. Promising, new antifungal agents and strategies are being developed and further refinement will facilitate their clinical use in the near future.

• Publication year

  2022

• Venue

  Medical Mycology

• Publication date

  2022-02-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/mmy/myac008PMID 35142862PMCID 8929677
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Neosartorya fischeri Antifungal Protein 2 (NFAP2): A New Potential Weapon against Multidrug-Resistant Candida auris Biofilms

  2021cited by this paper
• Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program

  2021cited by this paper
• Identification of Antifungal Compounds against Multidrug-Resistant Candida auris Utilizing a High-Throughput Drug-Repurposing Screen

  2021cited by this paper
• Outbreak of Candida auris infection in a COVID-19 hospital in Mexico

  2021cited by this paper
• Antifungal Activity of a Medical-Grade Honey Formulation against Candida auris

  2021cited by this paper
• Candida auris Outbreak in a COVID-19 Specialty Care Unit — Florida, July–August 2020

  2021cited by this paper
• Anticapsular and Antifungal Activity of α-Cyperone

  2021cited by this paper
• Spread of Carbapenem-Resistant Gram-Negatives and Candida auris during the COVID-19 Pandemic in Critically Ill Patients: One Step Back in Antimicrobial Stewardship?

  2021cited by this paper
• Facile Bio-Fabrication of Ag-Cu-Co Trimetallic Nanoparticles and Its Fungicidal Activity against Candida auris

  2021influential reference
• Candida auris: From Multidrug Resistance to Pan-Resistant Strains

  2020cited by this paper
• In Vitro Evaluation of Antifungal Drug Combinations against Multidrug-Resistant Candida auris Isolates from New York Outbreak

  2020cited by this paper
• Silver Nanoantibiotics Display Strong Antifungal Activity Against the Emergent Multidrug-Resistant Yeast Candida auris Under Both Planktonic and Biofilm Growing Conditions

  2020cited by this paper
• Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond.

  2020cited by this paper
• In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris

  2020cited by this paper
• NO Candida auris: Nitric Oxide in Nanotherapeutics to Combat Emerging Fungal Pathogen Candida auris

  2020cited by this paper
• Mutations in TAC1B: a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris

  2020cited by this paper
• In vitro antifungal activity of Cinnamomum zeylanicum bark and leaf essential oils against Candida albicans and Candida auris

  2020cited by this paper
• Synthesis of Silver Nanoparticles Using Curcumin-Cyclodextrins Loaded into Bacterial Cellulose-Based Hydrogels for Wound Dressing Applications

  2020cited by this paper
• Aprepitant, an antiemetic agent, interferes with metal ion homeostasis of Candida auris and displays potent synergistic interactions with azole drugs

  2020cited by this paper
• Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida auris

  2020cited by this paper
• Inhibition of Candida auris Biofilm Formation on Medical and Environmental Surfaces by Silver Nanoparticles.

  2020cited by this paper
• Efficacy of Ibrexafungerp (SCY-078) against Candida auris in an In Vivo Guinea Pig Cutaneous Infection Model

  2020cited by this paper
• Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris.

  2020cited by this paper
• Potent Synergistic Interactions between Lopinavir and Azole Antifungal Drugs against Emerging Multidrug-Resistant Candida auris

  2020cited by this paper
• Antifungal evaluation of traditional herbal monomers and their potential for inducing cell wall remodeling in Candida albicans and Candida auris

  2020cited by this paper
• A novel, quorum sensor-infused liposomal drug delivery system suppresses Candida albicans biofilms.

  2020cited by this paper
• Essential Oil-Based Design and Development of Novel Anti-Candida Azoles Formulation

  2020cited by this paper
• Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds

  2020cited by this paper
• Chitosan Ameliorates Candida auris Virulence in a Galleria mellonella Infection Model

  2020cited by this paper
• Broad‐Spectrum Antifungal Agents: Fluorinated Aryl‐ and Heteroaryl‐Substituted Hydrazones

  2020cited by this paper
• In vitro interaction of fluconazole and trimethoprim–sulfamethoxazole against Candida auris using ETEST and checkerboard methods

  2020cited by this paper
• Repurposing approach identifies pitavastatin as a potent azole chemosensitizing agent effective against azole-resistant Candida species

  2020cited by this paper
• An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris

  2020cited by this paper
• Pan-resistant Candida auris Isolates from the Outbreak in New York are Susceptible to Ibrexafungerp: A Glucan Synthase Inhibitor.

  2020cited by this paper
• Antifungal and anti‐biofilm effects of 6‐shogaol against Candida auris

  2020cited by this paper
• Bismuth Nanoantibiotics Display Anticandidal Activity and Disrupt the Biofilm and Cell Morphology of the Emergent Pathogenic Yeast Candida auris

  2020cited by this paper
• Sertraline as a promising antifungal agent: inhibition of growth and biofilm of Candida auris with special focus on the mechanism of action in vitro

  2020cited by this paper
• Oxadiazolylthiazoles as novel and selective antifungal agents.

  2020cited by this paper
• In vitro synergy of isavuconazole in combination with colistin against Candida auris

  2020cited by this paper
• Candida auris: a latent threat to critically ill patients with COVID-19

  2020cited by this paper
• Screening the CALIBR ReFRAME Library in Search for Inhibitors of Candida auris Biofilm Formation

  2020cited by this paper
• Novel 2-Aryloxazoline Compounds Exhibit an Inhibitory Effect on Candida spp., Including Antifungal-Resistant Isolates.

  2020cited by this paper
• Herbicides that target acetohydroxyacid synthase are potent inhibitors of the growth of drug resistant Candida auris.

  2020cited by this paper
• Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic Candida Species

  2020cited by this paper
• The Postbiotic Activity of Lactobacillus paracasei 28.4 Against Candida auris

  2020influential reference
• α-Cyperone Attenuates H2O2-Induced Oxidative Stress and Apoptosis in SH-SY5Y Cells via Activation of Nrf2

  2020cited by this paper
• Ospemifene displays broad-spectrum synergistic interactions with itraconazole through potent interference with fungal efflux activities

  2020cited by this paper
• Rezafungin In Vitro Activity against Contemporary Nordic Clinical Candida Isolates and Candida auris Determined by the EUCAST Reference Method

  2020cited by this paper
• Bismuth nanoparticles obtained by a facile synthesis method exhibit antimicrobial activity against Staphylococcus aureus and Candida albicans

  2020cited by this paper
• Combination of Miconazole and Domiphen Bromide Is Fungicidal against Biofilms of Resistant Candida spp

  2020cited by this paper
• A Cerberus-Inspired Anti-Infective Multicomponent Gatekeeper Hydrogel against Infections with the Emerging "Superbug" Yeast Candida auris.

  2020cited by this paper
• A Second-Generation Fungerp Analog, SCY-247, Shows Potent In Vitro Activity against Candida auris and Other Clinically Relevant Fungal Isolates

  2020cited by this paper
• Identification of disulfiram as a potential antifungal drug by screening small molecular libraries.

  2020cited by this paper
• Candida auris: An Emerging Yeast Pathogen Posing Distinct Challenges for Laboratory Diagnostics, Treatment, and Infection Prevention.

  2019cited by this paper
• Physical Interaction of Sodium Houttuyfonate With β-1,3-Glucan Evokes Candida albicans Cell Wall Remodeling

  2019cited by this paper
• Potential of Gallium as an Antifungal Agent

  2019cited by this paper
• Dissecting the Antimicrobial Composition of Honey

  2019cited by this paper
• Identification of a Phenylthiazole Small Molecule with Dual Antifungal and Antibiofilm Activity Against Candida albicans and Candida auris

  2019cited by this paper
• Effect of polyphenol-rich cranberry extracts on cariogenic biofilm properties and microbial composition of polymicrobial biofilms.

  2019cited by this paper
• Effects of the Natural Peptide Crotamine from a South American Rattlesnake on Candida auris, an Emergent Multidrug Antifungal Resistant Human Pathogen

  2019influential reference
• Sweet Relief: Determining the Antimicrobial Activity of Medical Grade Honey Against Vaginal Isolates of Candida albicans

  2019cited by this paper
• Farnesol increases the activity of echinocandins against Candida auris biofilms.

  2019cited by this paper
• Anticandidal activity of biosynthesized silver nanoparticles: effect on growth, cell morphology, and key virulence attributes of Candida species

  2019cited by this paper
• In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae

  2019cited by this paper
• Repositionable Compounds with Antifungal Activity against Multidrug Resistant Candida auris Identified in the Medicines for Malaria Venture’s Pathogen Box

  2019cited by this paper
• Microbial population dynamics under microdoses of the essential oil arborvitae

  2019cited by this paper
• Abrogation of Triazole Resistance upon Deletion of CDR1 in a Clinical Isolate of Candida auris

  2019cited by this paper
• Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol

  2019cited by this paper
• In Vitro Antifungal Susceptibility of the Emerging Multidrug-Resistant Pathogen Candida auris to Miltefosine Alone and in Combination with Amphotericin B

  2019cited by this paper
• ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients

  2019cited by this paper
• In Vitro Activity of Ibrexafungerp (SCY-078) against Candida auris Isolates as Determined by EUCAST Methodology and Comparison with Activity against C. albicans and C. glabrata and with the Activities of Six Comparator Agents

  2019cited by this paper
• In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris

  2019cited by this paper
• Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris

  2019cited by this paper
• Design of a Helical-Stabilized, Cyclic, and Nontoxic Analogue of the Peptide Cm-p5 with Improved Antifungal Activity

  2019cited by this paper
• Mode of action and anti-Candida activity of Artemisia annua mediated-synthesized silver nanoparticles.

  2019cited by this paper
• Potential Fifth Clade of Candida auris, Iran, 2018

  2019cited by this paper
• Effectiveness of Biosynthesized Trimetallic Au/Pt/Ag Nanoparticles on Planktonic and Biofilm Enterococcus faecalis and Enterococcus faecium Forms

  2019cited by this paper
• Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris

  2019cited by this paper
• Efficacy of antifungal drug combinations against widespread primary resistance, cross-resistance, and multidrug-resistance in Candida auris from New York Hospitals and Healthcare Facilities

  2019cited by this paper
• Polyphenol-Rich Cranberry Extracts Modulate Virulence of Streptococcus mutans-Candida albicans Biofilms Implicated in the Pathogenesis of Early Childhood Caries.

  2019cited by this paper
• Derivatives of the Antimalarial Drug Mefloquine Are Broad-Spectrum Antifungal Molecules with Activity against Drug-Resistant Clinical Isolates

  2019cited by this paper
• Synergistic antibacterial effects of curcumin modified silver nanoparticles through ROS-mediated pathways.

  2019cited by this paper
• Indifferent effect of nonsteroidal anti-inflammatory drugs (NSAIDs) combined with fluconazole against multidrug-resistant Candida auris

  2019cited by this paper
• The Novel Arylamidine T-2307 Demonstrates In Vitro and In Vivo Activity against Candida auris

  2019cited by this paper
• Distorted Gold(I)-Phosphine Complexes as Antifungal Agents.

  2019cited by this paper
• Broad-spectrum antifungal activities and mechanism of drimane sesquiterpenoids

  2019cited by this paper
• In Vitro Interaction of Geldanamycin with Triazoles and Echinocandins Against Common and Emerging Candida Species

  2019cited by this paper
• Fungal Quorum-Sensing Molecules and Inhibitors with Potential Antifungal Activity: A Review

  2019cited by this paper
• In Vitro Antifungal Combination of Flucytosine with Amphotericin B, Voriconazole, or Micafungin against Candida auris Shows No Antagonism

  2019cited by this paper
• In vitro characterization, ADME analysis, histological and toxicological evaluation of BM1, a macrocyclic amidinourea active against azole-resistant Candida strains.

  2019cited by this paper
• Probiotic Yeasts Inhibit Virulence of Non-albicans Candida Species

  2019cited by this paper
• Induction of antibacterial proteins and peptides in the coprophilous mushroom Coprinopsis cinerea in response to bacteria

  2018cited by this paper
• Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species

  2018cited by this paper
• Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris

  2018cited by this paper
• Five‐year profile of candidaemia at an Indian trauma centre: High rates of Candida auris blood stream infections

  2018cited by this paper
• Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms

  2018cited by this paper
• Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species

  2018influential reference
• APX001A In Vitro Activity against Contemporary Blood Isolates and Candida auris Determined by the EUCAST Reference Method

  2018cited by this paper
• Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris

  2018cited by this paper
• Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens

  2018cited by this paper

• Natural products eugenol and cinnamaldehyde as potential therapeutic alternatives against Candida auris infections.

  2025cites this paper
• Antifungal treatment strategies and their impact on resistance development in clinical settings

  2025cites this paper
• The Antidepressant Sertraline Modulates Gene Expression and Alternative Splicing Events in the Dermatophyte Trichophyton rubrum: A Comprehensive Analysis

  2025cites this paper
• Development of a novel family of antifungal agents based on a quinone methide oxime framework

  2025cites this paper
• Sphaeropsidin A Loaded in Liposomes to Reduce Its Cytotoxicity and Preserve Antifungal Activity Against Candida auris

  2024cites this paper
• Investigation of Virulence Factors of Candida albicans Species Isolated from Clinical Specimens Phenotypically and Genotypically

  2024cites this paper
• Candida auris Infection, a Rapidly Emerging Threat in the Neonatal Intensive Care Units: A Systematic Review

  2024cites this paper
• Fungal Foe and Mechanical Hearts: A Retrospective Case Series on Candida auris Bloodstream Infection With Left Ventricular Assist Devices

  2024cites this paper
• Uniqueness of Candida auris cell wall in morphogenesis, virulence, resistance, and immune evasion.

  2024cites this paper
• Unveiling Drimenol: A Phytochemical with Multifaceted Bioactivities

  2024cites this paper
• Recent Challenges in Diagnosis and Treatment of Invasive Candidiasis in Neonates

  2024cites this paper
• Azole Combinations and Multi-Targeting Drugs That Synergistically Inhibit Candidozyma auris

  2024cites this paper
• Overcoming amphotericin B resistance in Candida auris using the antiemetic drug rolapitant

  2024cites this paper
• Emergence of Candida auris in Vietnam: A case series

  2024cites this paper
• Perspectives on the Use of Echinocandins in the Neonatal Intensive Care Unit

  2024cites this paper
• Global characteristics and trends in research on Candida auris

  2023cites this paper
• Review of treatment options for a multi-drug resistant fungus: Candida auris.

  2023cites this paper
• Strategies to Prevent Transmission of Candida auris in Healthcare Settings

  2023cites this paper
• Broad sensitivity of Candida auris strains to quinolones and mechanisms of resistance

  2023cites this paper
• In Vitro Killing Activities of Anidulafungin and Micafungin with and without Nikkomycin Z against Four Candida auris Clades

  2023cites this paper
• A Candidemia Case Caused by a Novel Drug-Resistant Candida auris with the Y132F Mutation in Erg11 in Mainland China

  2023cites this paper
• Intra-clade Heterogeneity in Candida auris: Risk of Management

  2023cites this paper
• Broad susceptibility of Candida auris strains to 8-hydroxyquinolines and mechanisms of resistance

  2023cites this paper
• Nanotechnology-based fungal detection and treatment: current status and future perspective

  2023cites this paper
• Efficacy of octenidine- and chlorhexidine-based wash-mitts against Candida albicans and Candida auris - a comparative study.

  2023cites this paper
• Effectiveness of a sodium hypochlorite isotonic solution in decolonization of patients with Candida auris: learnings from a county healthcare system.

  2023cites this paper
• Fungal Forces in Mental Health: Microbial Meddlers or Function Fixers?

  2022cites this paper
• Diagnosis and Treatment of Invasive Candidiasis

  2022cites this paper
• Initial Results of the International Efforts in Screening New Agents against Candida auris

  2022cites this paper
• Small molecules for combating multidrug-resistant superbug Candida auris infections

  2022cites this paper
• Synergistic Interaction of Caspofungin Combined with Posaconazole against FKS Wild-Type and Mutant Candida auris Planktonic Cells and Biofilms

  2022cites this paper
• Challenges and opportunities in stewardship among solid organ transplant recipients with Candida auris bloodstream infections

  2022cites this paper
• Emerging Threats in Medical Mycology: A Comprehensive Review of Fungal Infections and the Rise of Candida Auris

  year unknowncites this paper